Chemed (CHE) Operating Expenses (2009 - 2026)

Chemed (CHE) has reported Operating Expenses for 18 consecutive years, with $572.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Expenses rose 3.76% year-over-year to $572.9 million; the TTM figure through Mar 2026 stood at $2.2 billion (up 5.35% YoY), while the FY2025 annual figure was $2.2 billion, up 6.15% from the prior year.
• Operating Expenses came in at $572.9 million for Q1 2026 at Chemed, up from $538.7 million in the prior quarter.
• The five-year high for Operating Expenses was $572.9 million in Q1 2026, with the low at $439.4 million in Q2 2022.
• Average Operating Expenses over 5 years is $502.6 million, with a median of $507.8 million recorded in 2024.
• Across the five-year window, Operating Expenses retreated 4.6% in 2022 and increased 10.87% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $465.3 million in 2022, then increased by 1.98% to $474.5 million in 2023, then gained by 10.87% to $526.1 million in 2024, then advanced by 2.39% to $538.7 million in 2025, then grew by 6.36% to $572.9 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $572.9 million, $538.7 million, and $550.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.